ES2094811T3 - Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos. - Google Patents

Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.

Info

Publication number
ES2094811T3
ES2094811T3 ES91908298T ES91908298T ES2094811T3 ES 2094811 T3 ES2094811 T3 ES 2094811T3 ES 91908298 T ES91908298 T ES 91908298T ES 91908298 T ES91908298 T ES 91908298T ES 2094811 T3 ES2094811 T3 ES 2094811T3
Authority
ES
Spain
Prior art keywords
salt
soluble
monovalent
solution
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908298T
Other languages
English (en)
Inventor
Paul A Tremblay
Frank Marziani
John A F Tino
Frank G Pilkiewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ES2094811T3 publication Critical patent/ES2094811T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6481—Phosphoglycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

SE PRESENTA UN METODO PARA PREPARAR UNA SAL MONOVALENTE SOLUBLE DE UN ESTER DE FOSFATIDIL QUE COMPRENDE LA REACCION DE UN FOSFOLIPIDO CON UN ALCOHOL PRIMARIO EN LA PRESENCIA DE UN CATALIZADOR DE ENZIMAS EN UNA SOLUCION CATIONICA DIVALENTE AMORTIGUADA Y UN SOLVENTE INMISCIBLE EN AGUA QUE NO ACTIVE LA ENZIMA, PARA FORMAR UNA SAL CATIONICA DIVALENTE DEL ESTER DE FOSFATIDIL, Y LA SUSPENSION DEL PRODUCTO EN LA PRESENCIA DE UNA CANTIDAD ESTOICOMETRICA DE UNA SAL CATIONICA MONOVALENTE CUYO ANION FORME UNA SAL INSOLUBLE CON EL CATION DIVALENTE. EL USO DE LA CROMATOGRAFIA DE PARTICION CENTRIFUGA FACILITA LA REACCION DE LA ENZIMA. LA SAL MONOVALENTE ES PREFERIBLEMENTE UNA SAL MEZCLADA DE AMONIO / SODIO.
ES91908298T 1990-04-17 1991-04-16 Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos. Expired - Lifetime ES2094811T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51328590A 1990-04-17 1990-04-17

Publications (1)

Publication Number Publication Date
ES2094811T3 true ES2094811T3 (es) 1997-02-01

Family

ID=24042616

Family Applications (2)

Application Number Title Priority Date Filing Date
ES96100985T Expired - Lifetime ES2132780T3 (es) 1990-04-17 1991-04-16 Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.
ES91908298T Expired - Lifetime ES2094811T3 (es) 1990-04-17 1991-04-16 Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES96100985T Expired - Lifetime ES2132780T3 (es) 1990-04-17 1991-04-16 Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.

Country Status (15)

Country Link
EP (2) EP0528834B1 (es)
JP (1) JP3169132B2 (es)
AT (2) ATE181747T1 (es)
AU (1) AU646458B2 (es)
CA (1) CA2080907C (es)
DE (2) DE69123145T2 (es)
DK (2) DK0727491T3 (es)
ES (2) ES2132780T3 (es)
GR (2) GR3022375T3 (es)
HU (1) HU212928B (es)
IE (1) IE911264A1 (es)
NZ (1) NZ237845A (es)
PT (1) PT97391B (es)
WO (1) WO1991016444A1 (es)
ZA (1) ZA912877B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
DE10142014B4 (de) * 2001-08-28 2004-11-11 Degussa Bioactives Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1900959A1 (de) * 1969-01-09 1970-08-27 Unilever Nv Verfahren zur Herstellung von Pflanzenphosphatiden mit universeller Emulgierkraft
US4235792A (en) * 1977-04-14 1980-11-25 The Governing Council Of The University Of Toronto Immunological materials
SU831129A1 (ru) * 1979-07-24 1981-05-23 Дальневосточный Государственный Уни-Верситет Способ получени фосфатидилглицерина
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4587055A (en) * 1982-05-26 1986-05-06 Research Corporation Polymerized vesicles and compounds for their preparation
DE3476770D1 (en) * 1983-04-11 1989-03-23 Meito Sangyo Kk Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique
JPS62205788A (ja) * 1986-03-05 1987-09-10 Shoichi Shimizu ホスフアチジルグリセロ−ル又はその誘導体の製造法
WO1989001524A1 (en) * 1987-08-14 1989-02-23 Liposome Technology, Inc. Method of preparing phosphatidylglycerol
US4997761A (en) * 1987-10-06 1991-03-05 Houston Biotechnology Incorporated Phosphatidyl treatment of viral disease
ES2063194T3 (es) * 1989-05-26 1995-01-01 Kao Corp Procedimiento de produccion de acido fosfatidico.

Also Published As

Publication number Publication date
PT97391B (pt) 1999-04-30
IE911264A1 (en) 1991-10-23
EP0727491B1 (en) 1999-06-30
DK0727491T3 (da) 1999-11-22
EP0528834A4 (en) 1993-06-02
JPH05509222A (ja) 1993-12-22
ES2132780T3 (es) 1999-08-16
ATE181747T1 (de) 1999-07-15
ZA912877B (en) 1992-12-30
DE69123145T2 (de) 1997-06-12
NZ237845A (en) 1993-06-25
DE69131404D1 (de) 1999-08-05
EP0528834A1 (en) 1993-03-03
EP0528834B1 (en) 1996-11-13
ATE145244T1 (de) 1996-11-15
WO1991016444A1 (en) 1991-10-31
HU9203258D0 (en) 1993-01-28
CA2080907C (en) 2001-08-14
EP0727491A1 (en) 1996-08-21
JP3169132B2 (ja) 2001-05-21
DE69123145D1 (en) 1996-12-19
AU7699591A (en) 1991-11-11
HU212928B (en) 1996-12-30
GR3031059T3 (en) 1999-12-31
GR3022375T3 (en) 1997-04-30
DK0528834T3 (da) 1997-04-07
HUT63198A (en) 1993-07-28
PT97391A (pt) 1991-12-31
AU646458B2 (en) 1994-02-24
CA2080907A1 (en) 1991-10-18
DE69131404T2 (de) 1999-11-25

Similar Documents

Publication Publication Date Title
ES534598A0 (es) Un procedimiento para preparar una solucion acuosa que contiene una sustancia farmaceutica soluble en lipidos
Pfeilschifter et al. Activation of phospholipase C and prostaglandin synthesis by [arginine] vasopressin in cultures
DE2964438D1 (en) Method of making solid medicaments with active agents applied in form of drops
ES8504690A1 (es) Un procedimiento para preparar una n-(4-(3-aminopropil)-aminobutil)-2-(acido w-guanidino-graso-amido)-2-alcoxietanamida
ES2019590B3 (es) Productos con contenido fosfolipido, fabricacion de los mismos y empleo.
ES2171278T3 (es) Presentacion en forma de lamina de dosis individual, que se descompone rapidamente en contacto con un liquido, y contiene una sustancia activa, en particular una sustancia aromatica.
ES2063194T3 (es) Procedimiento de produccion de acido fosfatidico.
AR245348A1 (es) Metodo de revestimiento
EA200101076A1 (ru) Сложные эфиры l-карнитина или алканоил l-карнитинов, полезные в качестве катионных липидов для внутриклеточной доставки фармакологически активных соединений
ES2094811T3 (es) Sintesis enzimatica de fosfatidos solubles a partir de fosfolipidos.
ES2026840T3 (es) Composicion alimenticia capaz de realizar una funcion de mejora de los lipidos del suero.
HUT38266A (en) Process for stabilizing vesiculum
ES522637A0 (es) Procedimiento para la preparacion de nuevas sustancias ws 6049.
PT84657B (pt) Processo para a fluidificacao, mediante glicofurol, de composicoes farmaceuticas contendo fosfatidil-colina, destinadas a serem introduzidas em capsulas moles de gelatina
FR2677897B1 (fr) Procede de preparation de particules submicroniques en presence de vesicules lipidiques et compositions correspondantes.
BR9007864A (pt) Composicao de limpeza abrasiva liquida
ES8502703A1 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES2110050T3 (es) Soluciones acuosas concentradas de sales de acido alquil eter carboxilico y procedimiento para la preparacion de las mismas.
ES2079349T3 (es) Sales por adicion de acidos de cefem cristalizadas y procedimiento para su preparacion.
FI916120A0 (fi) Foerfarande foer framstaellning av vattenhaltiga liposomsuspensioner som innehaoller ett aktivt aemne.
PT83204B (pt) Processo para a preparacao de composicoes farmaceuticas consistindo em fosfolipidos acilados
BR8702955A (pt) Processo para a preparacao de oligoglicosidios de alquila
ES8502435A1 (es) Un metodo para preparar 2(1h)-piridinonas
AU565084B2 (en) Succinic acid mono-dialkylamides as water-soluble corrosion inhibitors
DE69429719D1 (de) Aufnahme eines wasserlöslichen Wirkstoffes in einem Lipid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 528834

Country of ref document: ES